STAT Plus: Weeks after Kymera signed $70m deal with Vertex, the biotech’s CEO is out

Laurent Audoly, CEO and president of Kymera Therapeutics, left the Cambridge, Mass., biotech late last month, just weeks after the startup signed a $70 million business deal with Vertex Pharmaceuticals, company executives said Monday.

A news release issued by the privately held company said Audoly “has decided to pursue new entrepreneurial opportunities” but did not elaborate. He has been temporarily succeeded by Nello Mainolfi, a cofounder and the chief scientific officer of the firm.

Continue to STAT Plus to read the full story…

Read Original Article: STAT Plus: Weeks after Kymera signed $70m deal with Vertex, the biotech’s CEO is out »